Young early stage ovarian cancer patients can preserve...(d a total of 2911 women. While most of t...),Health
Navigation Links
Young early stage ovarian cancer patients can preserve fertility
Date:8/9/2009
d a total of 2,911 women. While most of the women underwent hysterectomy, about one in four (23 percent) had uterine preservation. Uterine preservation also had no effect on survival.
Women who were younger, who were diagnosed in more recent years, and who resided in the eastern or western United States were more likely to undergo ovarian or uterine conservation.
These results are promising for the many young women who are diagnosed with ovarian cancer each year. An estimated 21,650 women in the United States were diagnosed with the disease in 2008. "Given the potential reproductive and nonreproductive benefits of ovarian and uterine preservation, the benefits of conservative surgical management should be considered in young women with ovarian cancer," the authors concluded.
'/>"/>
| Contact: David Sampson david.sampson@cancer.org American Cancer Society Source:Eurekalert |
Related medicine news :
1. Health reform proposals could help 13 million uninsured young adults gain coverage
2. Young Vets With PTSD More Prone to Heart Risk Factors
3. EVO Merchant Services, CEO, Ray Sidhom Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in Metro New York
4. Young Kids Screen Time May Raise Blood Pressure
5. Cheerleading is Leading Cause of Catastrophic Injury in Young Women
6. Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy
7. Save Swine Flu Drugs for Younger Patients, Study Urges
8. Many Young Adults Uninformed About Vaccines
9. Young Adults Unaware of Threat of Infectious Disease and the Availability of Preventive Vaccines
10. CVS Caremark Charitable Trust Invests $300,000 in Easter Seals' Autism Services for Young Children
11. Young Innovations, Inc. Announces Record Earnings for the Quarter and Six-Months Ended June 30, 2009
Post Your Comments:
(Date:11/21/2009)... NEW YORK, Nov. 21 Milvia Lopez, b...k City, recently filed suit, in Supreme Court, New...plaint alleges that while Ms. Lopez underwent a ro...T. VINCENT,S HOSPITAL , doctors used an HIV infect...t alleges that several hours after being discharge...
(Date:11/21/2009)... NH based medical credentialing soft... industry to form a partnerhsip with Amerinet, Inc... partnership will help to transform quality care w... (Vocus) November 21, 2009 -- ISG Group, LLC,...d a new agreement with Amerinet Inc., a leading na...
(Date:11/21/2009)... New Haven Dental Group merges their... Branford, CT. , (PRWEB) ...omprised of partners Dr. David Gibson, Dr. Dean Cl...r has just merged their growing practice with that...When Dr. Pickman decided he wanted to retire from ...
(Date:11/20/2009)..., WASHINGTON, Nov. 20 T...ators to modify health care reform legislation rel...ding a health insurance individual coverage mandat...eable mandate will minimize adverse selection stem...prescribed by the bill. ,, "The individual mand...
(Date:11/20/2009)..., MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -...rus may have peaked in late October, but the pande...f illness in all age groups, including the elderly...ncorporated (NYSE: DGX ), the world,s leading pr...ices. ,, In its most recent Quest Diagnostics ...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3[0] Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure[0] IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care[0] New Haven Dental Group Expands Their Vision [0] Actuaries to Senate: Strengthen Individual Mandate[0] H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics
...tients vary widely in how they respond to treatmen...r Research and Therapy at the University of Arkans...bset of genes whose activity could predict high-ri...nsplant to create a genetic profile to chart the s...
...ancer survivors who took a weekly dose of risedron... than those who did not take the drug, according t...gh School of Medicine presented this week at the 2...er. , Susan Greenspan, M.D., director of the Oste...
...baxis, Inc.,(Nasdaq: ABAX ), a medical products c...systems, announced today that Clint Severson, CEO ... Life Science Conference on,Thursday, September 27...bb.ubs.com . Click on the conferences icon, then c...
... for a parent to be there for their,child,s first ...ventures,with Zachary between those two breaths.,"...ou to be a better person and to rely on,your faith... Moore (September 18, 2007, Boss Publishing Inc., ...
...experts at Johns Hopkins and in Brazil have eviden...n the regimen of drugs used to treat the highly co...horten the time needed to cure the illness from si...ive infections from their lungs (raising cure rate...
..., immune response, scientists say , TUESDAY, Sept....uman genome appears to be associated with rheumato...rom the Karolinska Institute, Stockholm, and elsew...n of the genome. This region, on chromosome 9, inc...
Other Medicine News:Health News:Gene profiling can single out the worst cases of multiple myeloma and guide therapy 2Health News:Gene profiling can single out the worst cases of multiple myeloma and guide therapy 3Health News:Weekly dose of osteoporosis drug prevents bone loss after breast cancer treatment 2Health News:Abaxis to Present at the 2007 UBS Global Life Science Conference 2Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 2Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 3Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 4Health News:New antibiotic drug combo to speed up treatment of tuberculosis 2Health News:New antibiotic drug combo to speed up treatment of tuberculosis 3Health News:New antibiotic drug combo to speed up treatment of tuberculosis 4Gene profiling can single out the worst cases of multiple myeloma and guide therapyWeekly dose of osteoporosis drug prevents bone loss after breast cancer treatmentAbaxis to Present at the 2007 UBS Global Life Science ConferenceOld at Age 3: The Inspiring Life of Progeria Patient Zachary MooreNew antibiotic drug combo to speed up treatment of tuberculosisGenome Area Linked to Rheumatoid Arthritis
(Date:11/20/2009)... Escalon Medical Corp. (N...fiscal first quarter ended September 30, 2009. ,... revenue decreased approximately $234,000, or 2.7%...d September 30, 2009 as compared to the same perio...eased net revenue of $8,434,000 compared with $8,6...
(Date:11/20/2009)... 20 /PRNewswire-FirstCall/ -- Landauer, Inc. (...scal fourth quarter and full year of 2009 pre-mark... will host a conference call for investors on Tues...Investors may access the live call by dialing 877-... 480-629-9835 (international callers), or by visit...
(Date:11/20/2009)...20 Reportlinker.com announces that...catalogue. ,, Pipettes & Pipettors - A Glo...inker.com/p0164373/Pipettes--Pipettors---A-Global-...utm_medium=pr&utm_campaign=prnewswire ,, ...part of any research laboratory. Large-scale appli...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 1VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 2VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 3VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 5976 4Company Appoints New SVP Marketing for PBM Business 5974 1Company Appoints New SVP Marketing for PBM Business 5974 2Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascents Neurogenesis Platform 5972 1Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascents Neurogenesis Platform 5972 2...stained Improvement in Signs and,Symptoms Of Moder...of Patients Achieving Disease Remission at One-Y...One-year data show nearly,75 percent of patients w...eceiving golimumab (CNTO 148) and methotrexate (MT...improvement in,arthritis symptoms (ACR 20). This w...
...thews - June 14, 2007) - Ambrilia,Biopharma Inc. (...ovel small molecules and peptides to treat infecti...nd Special Meeting today, during,which the data re...ase inhibitors and recent developments were highli... of the Board, Mr. Frederic,Porte, and a progress ...
Other Medicine Technology:Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Clearview EASY LH (Non-CE marked)
Careplan VpH Test Gloves
Clearview HCG COMBO
ZyDoc® e-Transcription Solutions
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |